THE ORGANIZATION'S MISSION IS TO PROVIDE FUNDING FOR THE BEST CANCER RESEARCH IDEAS IN SAN DIEGO. ALL PROCEEDS FROM CUREBOUND STAY IN SAN DIEGO TO FUND INNOVATIVE AND COLLABORATIVE CANCER RESEARCH.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$16.4M
-32.6% YoY
Annual Giving
$7.1M
Grant Count
10
Avg Grant Size
$708K
About Curebound
Based on IRS filings
Curebound is a nonprofit organization focused on Diseases, Disorders & Medical Disciplines, based in SAN DIEGO, CA. IRS filing data is available from 2019 through 2024. As of 2024, the organization holds $16.4M in total assets. In 2024, it awarded 10 grants totaling $7.1M. Net investment income was $522K.
Focus Areas
Ready to take the next step with Curebound?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $16,440,883 | $24,388,123 | $23,579,083 |
| Revenue | $5,488,901 | $10,395,528 | $19,804,413 |
| Expenses | $10,744,443 | $12,500,342 | $6,229,069 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $522,299 | $246,733 | $48 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
10 grants across all recorded years
Giving History
Grant recipients and amounts by year
Among its reported 2024 grants, the largest include The Regents of University of California Uc San Diego ($4,721,574), La Jolla Institute for Immunology ($532,374), Sanford Burnham Prebys ($411,561).
| Recipient | Purpose | Amount |
|---|---|---|
| LA JOLLA INSTITUTE FOR IMMUNOLOGY LA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $532,374 |
| RADY CHILDREN'S HOSPITAL SAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $21,431 |
| SANFORD BURNHAM PREBYS LA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $411,561 |
| SCRIPPS RESEARCH LA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $188,618 |
| THE REGENTS OF UNIVERSITY OF CALIFORNIA UC SAN DIEGO LA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $4,721,574 |
| THE SALK INSTITUTE FOR BIOLOGICAL STUDIES LA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $207,926 |
| BEKEN BIO INC SAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 |
| SEREN BIO CORP ENCINITAS, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 |
| PALM THERAPEUTICS INC SAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 |
| RESOLUTE SCIENCE INC SAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 |
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| FE WHITWORTH | DIRECTOR | 1 | — |
| CHERYL AM ANDERSON | DIRECTOR | 1 | — |
| LARRY BLOCH | DIRECTOR | 1 | — |
| MARK CAFFERTY | DIRECTOR | 1 | — |
| AARON DAVIS | DIRECTOR | 1 | — |
| RICH HEYMAN | DIRECTOR | 1 | — |
| JOHN HOOD | DIRECTOR | 1 | — |
| CATRIONA JAMIESON | DIRECTOR | 1 | — |
| DONALD B KEARNS | DIRECTOR | 1 | — |
| JULIE TAFEL KLAUS | DIRECTOR | 1 | — |
| MAGDA MARQUET | DIRECTOR | 1 | — |
| DAN RYAN | DIRECTOR | 1 | — |
| ROB SINGH | DIRECTOR | 1 | — |
| HAEYOUNG TANG | DIRECTOR | 1 | — |
| CHRIS TRESSE | DIRECTOR | 1 | — |
| COURT TURNER | DIRECTOR | 1 | — |
| BILL KOMAN | CHAIRPERSON | 1 | — |
| RICK VALENCIA | VICE-CHAIR | 1 | — |
| ROBIN TOFT | SECRETARY | 1 | — |
| DON ANKENY | TREASURER | 1 | — |
| ANNE MARBARGER | CHIEF EXECUTIVE OFFICER | 40 | $385,000 |
| KAREN HOOPER | CHIEF OPERATING OFFICER | 40 | $230,000 |
| DANIELLE DAWSON | PHILANTHROPY OFFICER | 40 | $221,250 |
| HEATHER DEAN-PRESNALL | SR. DIRECTOR, STEWARDSHIP + REVENUE STRATEGY | 40 | $125,000 |
| MEGAN AMBROSE | CHIEF OF STAFF | 40 | $113,937 |
Subject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What is Curebound?
Curebound is a nonprofit organization focused on Diseases, Disorders & Medical Disciplines, based in SAN DIEGO, CA. It holds $16.4M in total assets as of 2024.
How large is Curebound?
As of 2024, Curebound holds $16.4M in total assets with $5.5M in annual revenue. It awarded 10 grants totaling $7.1M in 2024.
Where does Curebound operate?
Curebound has awarded grants in California.
What size grants does Curebound award?
In 2024, Curebound awarded 10 grants totaling $7.1M — an average of about $708K per grant, based on its IRS Form 990 filings.
What is Curebound's EIN?
Curebound's EIN (Employer Identification Number) is 46-0552414. IRS Form 990 filing data is available on this page for 2019–2024.
Explore Open Grants
Browse active grant opportunities in Curebound's focus areas in our free grants database
Related Funders
Similar funders by location and focus area
Gochnauer Family Foundation
CORONA DEL MAR, CA
Assets
$15.2M
Grants
39
Total Given
$313K
Cottage Health
SANTA BARBARA, CA
Assets
$172.1M
Grants
6
Total Given
$179K
International Right of Way Association
GARDENA, CA
Assets
$5.7M
Grants
1
Total Given
$9K
Quince Interfaith Housing Corporation
LEMON GROVE, CA
Assets
—
Grants
0
Total Given
—
William & Lillian Schwartz Charitable Foundation
LA JOLLA, CA
Assets
$325K
Grants
1
Total Given
$3K
Covia Foundation
GLENDALE, CA
Assets
$15.2M
Grants
1
Total Given
$4.8M
Data last updated April 2026. Sourced from IRS Form 990-PF filings.
What could you do with Curebound on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities
Go from researching Curebound to a real strategy.